Federal health advisers say a brain stimulating device from Medtronic can be approved for epilespy, provided the company conducts follow-up safety studies. The Food and Drug Administration's panel of neurological experts voted 7-5 in favor of Medtronic's Deep Brain Stimulation implant, under certain conditions. The experts said it should carry warning about depression and memory loss. They also ...

Medical device maker Medtronic says federal prosecutors are investigating its relationship with cardiologists at a hospital in Massachusetts. In regulatory filings with the government, Medtronic said it has been asked to hand over documents to the U.S. Attorney's Office for the District of Massachusetts. The attorneys are seeking information about Medtronic's CoreValve division and its relationship with ...

The Food and Drug Administration has posted its review of a Medtronic device that treats seizures by stimulating areas of the brain used for movement. UNSTIMULATING RESULTS: The FDA said Medtronic's study of the device in epilepsy patients missed its goal of showing reduced seizures during a three-month period. ONE-PATIENT PROBLEM: Medtronic attributed the missed study goal to one ...

Medtronic said Tuesday its third-quarter profit rose 19 percent on robust sales of defibrillators and diabetes products. Still, lackluster sales of pacemakers and spine implants cut into revenue and company shares dipped in early trading along with the broader market. Chief Executive Bill Hawkins told analysts he ...